471 related articles for article (PubMed ID: 12969225)
21. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
[TBL] [Abstract][Full Text] [Related]
23. [Expression of p53 and Ki-67 genes in epithelial dysplasia from old oral mucosa and clinical significance].
Zhao J; Guo B; Ma SC; Zhou XD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):689-91. PubMed ID: 16235539
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
25. Quantitative cell-cycle protein expression in oral cancer assessed by computer-assisted system.
Soares CP; Zuanon JA; Teresa DB; Fregonezi PA; Neto CB; Oliveira MR; Donadi EA; Martinelli-Kläy CP; Soares EG
Histol Histopathol; 2006 Jul; 21(7):721-8. PubMed ID: 16598671
[TBL] [Abstract][Full Text] [Related]
26. Podoplanin expression as a predictive marker of dysplasia in oral leukoplakia.
Gissi DB; Gabusi A; Tarsitano A; Luccarini L; Morandi L; Montebugnoli L
J Craniomaxillofac Surg; 2018 May; 46(5):759-764. PubMed ID: 29588189
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
28. [Expression of integrin-beta1 in oral leukoplakia and early invasive carcinoma and its relationship with cell proliferation].
Shang JW; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Oct; 43(10):608-11. PubMed ID: 19087624
[TBL] [Abstract][Full Text] [Related]
29. p53 immunoprofiling of potentially malignant oral disorders: a case series analysis.
Reddy VM; Kamath A; Radhakrishnan RA
Indian J Cancer; 2012; 49(1):27-32. PubMed ID: 22842165
[TBL] [Abstract][Full Text] [Related]
30. Aspects of cell proliferation in oral epithelial dysplastic lesions.
Oliver RJ; MacDonald DG; Felix DH
J Oral Pathol Med; 2000 Feb; 29(2):49-55. PubMed ID: 10718399
[TBL] [Abstract][Full Text] [Related]
31. Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma.
Vered M; Allon I; Dayan D
J Oral Pathol Med; 2009 Mar; 38(3):314-20. PubMed ID: 18783348
[TBL] [Abstract][Full Text] [Related]
32. [Immunohistochemical analysis of the p53 tumor suppressor gene product in oral leukoplakia].
Kikegawa A
Kokubyo Gakkai Zasshi; 2001 Mar; 68(1):51-9. PubMed ID: 11321806
[TBL] [Abstract][Full Text] [Related]
33. E-cadherin downregulation and Twist overexpression since early stages of oral carcinogenesis.
de Freitas Silva BS; Yamamoto-Silva FP; Pontes HA; Pinto Júnior Ddos S
J Oral Pathol Med; 2014 Feb; 43(2):125-31. PubMed ID: 23772858
[TBL] [Abstract][Full Text] [Related]
34. Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Takamori K; Igawa K; Yoshida M; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2006 May; 35(5):301-6. PubMed ID: 16630294
[TBL] [Abstract][Full Text] [Related]
35. Association between p62 expression and clinicopathological characteristics in oral leukoplakia.
Yoshida T; Terabe T; Nagai H; Uchida F; Hasegawa S; Nagao T; Miyabe S; Ishibashi-Kanno N; Yamagata K; Warabi E; Gosho M; Yanagawa T; Bukawa H
Clin Exp Dent Res; 2019 Aug; 5(4):389-397. PubMed ID: 31452949
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
37. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth.
Kushner J; Bradley G; Jordan RC
J Pathol; 1997 Dec; 183(4):418-23. PubMed ID: 9496258
[TBL] [Abstract][Full Text] [Related]
38. Suprabasal expression of Ki-67 antigen as a marker for the presence and severity of oral epithelial dysplasia.
Gonzalez-Moles MA; Ruiz-Avila I; Rodriguez-Archilla A; Martinez-Lara I
Head Neck; 2000 Oct; 22(7):658-61. PubMed ID: 11002319
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
Shintani S; Yoshihama Y; Emilio AR; Matsumura T
Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
[TBL] [Abstract][Full Text] [Related]
40. Oral leukoplakias with different degrees of dysplasia: comparative study of hMLH1, p53, and AgNOR.
Caldeira PC; Aguiar MC; Mesquita RA; do Carmo MA
J Oral Pathol Med; 2011 Apr; 40(4):305-11. PubMed ID: 21208285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
